INTRODUCTION
Alzheimer's disease (AD) is a neurodegenerative disease that is strongly correlated with aging, and its prevalence globally has dramatically increased as the lifespan of the world's population has increased. AD is clinically characterized by severe memory loss, impairment of cognitive performance and personality changes (1). Oxidative stress is a key component of the AD pathological cascade (2). Oxidative stress, as measured by many parameters, including the modification of DNA, lipid peroxidation, protein oxidation and ROS formation, has been observed in the neurodegenerative brain tissue of AD patients (3, 4). Several studies have suggested that amyloid beta (Aβ) peptide induced the oxidative stress observed in the neurodegenerative AD brain (5-7). The presence of Aβ plaques is one of the major pathological hallmarks of AD (8). This disease is thought to be caused by the accumulation of Aβ to the extent that the Aβ level reach a toxic level in the brain (9). It has been known that Aβ peptide-induced toxicity is mediated by free radicals, which cause lipid peroxidation of neural cell membranes via inhibition of antioxidants (10, 11). Proper intracellular balance of oxidants and antioxidants is vital for cell function and an imbalance of the oxidative state is involved in much of the pathology mediated by free radicals (12). Therefore, antioxidant therapies have been investigated as a potential means to reduce reactive oxygen species (ROS)-based damage in AD. Natural antioxidant products are thought to be promising potential candidate neuroprotective agents because natural antioxidants such as phytochemicals have been shown to prevent neuronal cell death via scavenging of free radicals and enhancing the cellular antioxidant system. Licorice (the roots of Glycyrrhiza inflate) has been used in folk medicine to relieve rheumatic and other types of pain and is also known to have a healing effect on ulcers (13). Retrochalcones, including echinatin and the licochalcone series (licochalcone A-E), have been isolated from licorice, and have been shown to produce antioxidative effects such as the scavenging of superoxide (13), as well as anti-bacterial (14), anti-inflammatory (15) and anti-diabetic (16) activities. In this study, we synthesized new chalcone derivatives based on retrochalcone from licorice and investigated the protective effects of these synthesized chalcones on Aβ peptide-induced oxidative damage via free radical scavenging in vitro and determine if these chalcones could reduce learning and memory deficits in Aβ-treated mice.
RESULTS AND DISCUSSION
Free radical scavenging activity and the effects on cell viability of the Chana series
The free radical scavenging activity of the synthetic chalcone series, Chana 1 to 40, was screened using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. In this screen, Chana 30 was shown to have the highest scavenging activity among the Chana compounds (Fig.1B) . In fact, the scavenging activity of Chana 30 was also significantly higher than that of epigallocatechin http://bmbreports.org BMB reports gallte (EGCG), which was used as a positive control. Chana 28 and 29 also exhibited scavenging activities that were higher than of the other Chana compounds. To ensure that the compounds with increased scavenging ability were not toxic to cells, the viability of PC12 cells was monitored by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after the cells were treated with Chana 28, 29, and 30 ( Fig. 1  C) . Cells were treated with Chana 28, 29, or 30 at 10 and 20 μM for 24 h, and ascorbic acid was used as a positive control. 10
μM of all three of the Chana series compounds (28, 29 and 30) reduced cell viability by less than 20%. Interestingly, the viability of cells treated with the natural retrochalcone, Licochalcone E (Lico E), was lower than that of those treated with Chana 28, 29 or 30.
Protective effects of Chana chalcones against Aβ-induced cytotoxicity in vitro
To examine the protective effects of the selected Chana compounds (28-30) against Aβ1-42-induced neuronal cell death, cell viability was measured in PC12 cells treated with these compounds and Aβ1-42. Aβ1-42 treatment of PC12 cells decreased cell viability by 37.33 ± 1.28% compared to control cells (Fig.  2) . Among the selected Chana compounds, only Chana 30 at 10 μM significantly protected the cells against the effects of Aβ1-42. Aβ peptides have been shown to induce the peroxidation of lipids and proteins (10), and this activity may at least in part account for the neurodegeneration in AD brains (8). Recent evidence has indicated that natural compounds with antioxidant activity can reduce oxidative stress and exhibit neuroprotective effects. Caffeic acid derivatives from romaine lettuce (17), acubin from Eucommia ulmoides japonica (18) and anthocyanins from strawberries (19) have all been shown to reduce oxidative-induced neurodegenerative damage and retrochalcones have been previously reported to have free radical scavenging activity (13). In this study, the scavenging activity of Chana 30 was found to be similar to that of EGCG and higher than that of licochalcone E, and Chana 30 at 10 μM protected cells from Aβ peptide-induced neuronal cell death (Fig. 
